Matches in SemOpenAlex for { <https://semopenalex.org/work/W810408096> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W810408096 endingPage "591" @default.
- W810408096 startingPage "583" @default.
- W810408096 abstract "This 8-week, randomized, double-blind, placebo-controlled study, conducted August 2010-May 2012 in the United States, evaluated the safety and efficacy of vortioxetine 10 mg and 15 mg in patients with major depressive disorder (MDD). The mechanism of action of vortioxetine is thought to be related to direct modulation of serotonin (5-HT) receptor activity and inhibition of the serotonin transporter.Adults aged 18-75 years with MDD (DSM-IV-TR) and Montgomery-Asberg Depression Rating Scale (MADRS) total score ≥ 26 were randomized (1:1:1) to receive vortioxetine 10 mg or 15 mg or placebo once daily, with the primary efficacy end point being change from baseline at week 8 in MADRS analyzed by mixed model for repeated measures. Adverse events were recorded during the study, suicidal ideation and behavior were assessed using the Columbia-Suicide Severity Rating Scale (C-SSRS), and sexual dysfunction was assessed using the Arizona Sexual Experience (ASEX) scale.Of the 1,111 subjects screened, 469 subjects were randomized: 160 to placebo, 157 to vortioxetine 10 mg, and 152 to vortioxetine 15 mg. Differences from placebo in the primary efficacy end point were not statistically significant for vortioxetine 10 mg or vortioxetine 15 mg. Nausea, headache, dry mouth, constipation, diarrhea, vomiting, dizziness, and flatulence were reported in ≥ 5% of subjects receiving vortioxetine. Discontinuation due to adverse events occurred in 7 subjects (4.4%) in the placebo group, 8 (5.2%) in the vortioxetine 10 mg group, and 12 (7.9%) in the vortioxetine 15 mg group. ASEX total scores were similar across groups. There were no clinically significant trends within or between treatment groups on the C-SSRS, laboratory values, electrocardiogram, or vital sign parameters.In this study, vortioxetine did not differ significantly from placebo on MADRS total score after 8 weeks of treatment in MDD subjects.ClinicalTrials.gov identifier: NCT01179516." @default.
- W810408096 created "2016-06-24" @default.
- W810408096 creator A5024369212 @default.
- W810408096 creator A5065881205 @default.
- W810408096 creator A5068791484 @default.
- W810408096 creator A5081426855 @default.
- W810408096 creator A5089404250 @default.
- W810408096 date "2015-05-27" @default.
- W810408096 modified "2023-10-14" @default.
- W810408096 title "A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Vortioxetine in Adults With Major Depressive Disorder" @default.
- W810408096 cites W1970755410 @default.
- W810408096 cites W1987514922 @default.
- W810408096 cites W1992333267 @default.
- W810408096 cites W1993810702 @default.
- W810408096 cites W2011606125 @default.
- W810408096 cites W2029732660 @default.
- W810408096 cites W2036812642 @default.
- W810408096 cites W2048026164 @default.
- W810408096 cites W2054766240 @default.
- W810408096 cites W2058572593 @default.
- W810408096 cites W2059274457 @default.
- W810408096 cites W2061669920 @default.
- W810408096 cites W2064563389 @default.
- W810408096 cites W2071735605 @default.
- W810408096 cites W2086325363 @default.
- W810408096 cites W2131823335 @default.
- W810408096 cites W2159271064 @default.
- W810408096 cites W2160070901 @default.
- W810408096 cites W2164182651 @default.
- W810408096 cites W2336200589 @default.
- W810408096 doi "https://doi.org/10.4088/jcp.14m09337" @default.
- W810408096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26035186" @default.
- W810408096 hasPublicationYear "2015" @default.
- W810408096 type Work @default.
- W810408096 sameAs 810408096 @default.
- W810408096 citedByCount "66" @default.
- W810408096 countsByYear W8104080962015 @default.
- W810408096 countsByYear W8104080962016 @default.
- W810408096 countsByYear W8104080962017 @default.
- W810408096 countsByYear W8104080962018 @default.
- W810408096 countsByYear W8104080962019 @default.
- W810408096 countsByYear W8104080962020 @default.
- W810408096 countsByYear W8104080962021 @default.
- W810408096 countsByYear W8104080962022 @default.
- W810408096 countsByYear W8104080962023 @default.
- W810408096 crossrefType "journal-article" @default.
- W810408096 hasAuthorship W810408096A5024369212 @default.
- W810408096 hasAuthorship W810408096A5065881205 @default.
- W810408096 hasAuthorship W810408096A5068791484 @default.
- W810408096 hasAuthorship W810408096A5081426855 @default.
- W810408096 hasAuthorship W810408096A5089404250 @default.
- W810408096 hasBestOaLocation W8104080961 @default.
- W810408096 hasConcept C118552586 @default.
- W810408096 hasConcept C126322002 @default.
- W810408096 hasConcept C142724271 @default.
- W810408096 hasConcept C15744967 @default.
- W810408096 hasConcept C168563851 @default.
- W810408096 hasConcept C197934379 @default.
- W810408096 hasConcept C204787440 @default.
- W810408096 hasConcept C27081682 @default.
- W810408096 hasConcept C2778034309 @default.
- W810408096 hasConcept C2780051608 @default.
- W810408096 hasConcept C2780580376 @default.
- W810408096 hasConcept C2780733359 @default.
- W810408096 hasConcept C71924100 @default.
- W810408096 hasConceptScore W810408096C118552586 @default.
- W810408096 hasConceptScore W810408096C126322002 @default.
- W810408096 hasConceptScore W810408096C142724271 @default.
- W810408096 hasConceptScore W810408096C15744967 @default.
- W810408096 hasConceptScore W810408096C168563851 @default.
- W810408096 hasConceptScore W810408096C197934379 @default.
- W810408096 hasConceptScore W810408096C204787440 @default.
- W810408096 hasConceptScore W810408096C27081682 @default.
- W810408096 hasConceptScore W810408096C2778034309 @default.
- W810408096 hasConceptScore W810408096C2780051608 @default.
- W810408096 hasConceptScore W810408096C2780580376 @default.
- W810408096 hasConceptScore W810408096C2780733359 @default.
- W810408096 hasConceptScore W810408096C71924100 @default.
- W810408096 hasIssue "05" @default.
- W810408096 hasLocation W8104080961 @default.
- W810408096 hasLocation W8104080962 @default.
- W810408096 hasOpenAccess W810408096 @default.
- W810408096 hasPrimaryLocation W8104080961 @default.
- W810408096 hasRelatedWork W2105567689 @default.
- W810408096 hasRelatedWork W2303297560 @default.
- W810408096 hasRelatedWork W2585266158 @default.
- W810408096 hasRelatedWork W2742151531 @default.
- W810408096 hasRelatedWork W2748952813 @default.
- W810408096 hasRelatedWork W282266550 @default.
- W810408096 hasRelatedWork W3172359983 @default.
- W810408096 hasRelatedWork W4206654604 @default.
- W810408096 hasRelatedWork W4210538666 @default.
- W810408096 hasRelatedWork W2183331092 @default.
- W810408096 hasVolume "76" @default.
- W810408096 isParatext "false" @default.
- W810408096 isRetracted "false" @default.
- W810408096 magId "810408096" @default.
- W810408096 workType "article" @default.